000			04040nam a22004455i 4500
998			_b10/2022 _dz _eu _zSI
999			_c383684 _d383684 _x1
001			383684
003			ES-MaUEC
005			20230102122142.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			201010s2021 sz | s |||| 0|eng d
020			_a9783030536336
024	7		_a10.1007/978-3-030-53633-6 _2doi
040			_bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC643 _b2021 EB
245	0	0	_aAcute Leukemias _cedited by Stefan H. Faderl, Hagop M. Kantarjian, Elihu Estey
250			_a2nd edition 2021
264		1	_aCham _bSpringer International Publishing _c2021
300			_a1 recurso en línea (VI, 289 páginas) _b30 ilustraciones, 23 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aarchivo de texto _bPDF
490	0		_aHematologic Malignancies _x2197-9774
505	0		_aPart I Acute Myeloid Leukemia -- Acute Myeloid Leukemia: Epidemiology and Etiology -- Clinical Presentation, Diagnosis and Classification of Acute Myedloid Leukemia -- Selection of Patients for Therapy -- Therapy of Newly Diagnosed AML -- Management of Relapsed and Refractory AML -- Stem cell Transplant in AML -- Investigational Therapies in AML -- Acute Lymphoblastic Leukemia -- Acute Lymphoblastic Leukemia: Epidemiology abnd Etiology -- Molecular Biology and Genetics -- Acute Lymphoblastic Leukemia: Clinical Presentation, Diagnosis, and Classification -- Therapy of Newly Diagnosed Adult ALL -- Approach to Newly Diagnosed Pediatric and AYA ALL -- The Role of Immunotherapy in ALL -- STem Cell Transplantation in the Treatment of ALL -- The Significance of Minimal Residual Disease in Acute Lymphoblastic Leukemia -- Philadelphia Chromosome - Positive Acute Lymphoblastic Leukemia -- BCR-ABL-like ALL: Diagnosis and Management -- Burkitt's Acute Lymphoblastic Leukema in Adults -- Treatment of Lymphoblastic Lymphoma in Adults -- Central Nervous System Involovment in Adult Acute Lymphocytic Leukemia -- Management of Relapsed and Refractory ALL -- Emergencies in Acute Lymphoblastic Leukema -- Investigational Therapies in ALL.
520	3		_aThe new edition of this well-received book provides a timely update of current knowledge on the biology, disease classification, and treatment of the acute leukemias - acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Throughout, the focus is on the provision of state of the art information and guidance that will meet the needs of clinicians. Chapters have been extensively revised to take into account advances in understanding and management that have been achieved over the past few years. In addition, new chapters have been included on selection of AML patients for therapy, a broader discussion of stem cell transplantation in AML, the role of immunotherapy in ALL, the approach to newly diagnosed pediatric ALL, and the diagnosis and management of BCR-ABL-like ALL. New therapies, including investigational ones, are fully covered. As progress continues in the management of acute leukemias this book will be a valuable asset for clinicians at all levels of experience.
988			_aSpringer_Medicine_2021
650		7	_2embne _9140673 _aLeucemia
700	1		_aFaderl, Stefan H. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aKantarjian, Hagop M. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aEstey, Elihu _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9783030536329
776	0	8	_iPrinted edition: _z9783030536343
776	0	8	_iPrinted edition: _z9783030536350
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-53633-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE